SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?


To: DRRISK who wrote (1121)2/25/1998 9:44:00 AM
From: Worswick  Read Replies (1) | Respond to of 2068
 
This board certainly has gotten lively again.

There are a number of good articles published today in the NY Times which perhaps will escape people's notice so here is the link.

nytimes.com

I think there are four to five more articles under the banner head.

Plese, between times, I think some of you have lostsight of thefactthat Price and Texas Pacific are in this to make money. Their returns are often quite stunning. These people have looked at the books. They invested. This is a huge vote of conficdence for this company's prospects. KKR has the reputation of sometimes wanting all the pie for itself.



To: DRRISK who wrote (1121)2/25/1998 9:49:00 AM
From: Premier  Read Replies (2) | Respond to of 2068
 
I love your slogan. Replay of yesterday's CC can be heard on 888 566 0615 PIN 236.

Yesterday's call appears to have been directed towards press not analysts. Oxford has taken PR at consumer level as its priority. Payson's priority appears to be to cut on unprofitable lines and unprofitable regions. New York appears to be growth area for him. he will tap into management resource from healthsource.

The road ahead is bumpy. Oxford is a candidate for takeover but not that soon. Buying on dips and lightening on strength appears to be good short term strategy. I view this stock to be log term hold.

Premier